International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7951220
Original Article
Study of Risk Factors for DVT in Patients Post Various Abdominal Surgeries
 ,
 ,
 ,
 ,
Published
May 19, 2023
Abstract
Background: Deep vein thrombosis (DVT) is a common complication in patients undergoing abdominal surgery. This study aimed to identify the risk factors associated with the development of DVT in patients following abdominal surgery. Methods: A prospective observational study was conducted on 100 patients who underwent abdominal surgery between January 2022 and December 2022. Demographic data, comorbidities, surgery-related factors, and postoperative care measures were collected. Logistic regression analysis was performed to identify the risk factors associated with the development of DVT. Results: The incidence of DVT in this patient population was 4.9%. Logistic regression analysis revealed that patients who underwent major abdominal surgery for malignancy and those with surgery duration of ≥2 hours were at significantly higher risk of developing DVT post-surgery. Age, sex, BMI, and comorbidities such as hypertension, diabetes, and smoking were not significant risk factors. Prophylactic anticoagulants, mechanical compression devices, and early mobilization did not show a significant effect on the development of DVT. Conclusions: This study suggests that patients who undergo major abdominal surgery for malignancy and those with surgery duration of ≥2 hours are at higher risk of developing DVT post-surgery. Clinicians should be aware of these risk factors and take appropriate measures to prevent DVT in these high-risk patients. Future studies are needed to further evaluate the effectiveness of prophylactic measures in preventing DVT in post-surgical patients.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2053 Views
293 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved